Bisphosphonates in Paget's disease

Bisphosphonates in Paget's disease,10.1016/j.bone.2010.09.002,Bone,Ian R. Reid,D. J. Hosking

Bisphosphonates in Paget's disease   (Citations: 1)
BibTex | RIS | RefWorks Download
Paget's disease is the best example of a common high turnover bone disease. A review of the early use of bisphosphonates in the treatment of this condition shows that many of the fundamental therapeutic issues were identified using drugs which by today's standards were far from ideal. Over the succeeding decades there has been a steady increase in potency culminating in the introduction of intravenous zoledronic acid which is capable of inducing long term remissions which were unthinkable when bisphosphonates were first introduced.This article is part of a Special Issue entitled Bisphosphonates.
Journal: Bone , vol. 49, no. 1, pp. 89-94, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: